StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.87+0.05 (+1.77%)

Close on Nov 13, 2026Market cap $25.87MP/E –Yield –

Nasus Pharma cash

Cash and short-term investments held at the end of each period.

Nasus Pharma's cash was $7.82M at Jun 30, 2026. For fiscal 2025 it was $1.24M, up 335.6% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.24M+335.6%
FY2024Dec 31, 2024$284.00K+47.2%
FY2023Dec 31, 2023$193.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.82M+768.7%
Q4 FY2025Dec 31, 2025$1.24M+540.9%
Q2 FY2025Jun 30, 2025$203.00K–
Q4 FY2024Dec 31, 2024$284.00K–
Q2 FY2024Jun 30, 2024$900.00K–
Q4 FY2023Dec 31, 2023$193.00K–

More Nasus Pharma figures

See a number that looks wrong?